Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
The master cytokine TGF-β mediates tissue fibrosis associated with inflammation and tissue injury. TGF-β induces fibroblast activation and differentiation into myofibroblasts that secrete extracellular matrix proteins. Canonical TGF-β signaling mobilizes Smad2 and Smad3 transcription factors that control fibrosis by promoting gene expression. However, the importance of TGF-β-Smad2/3 signaling in fibroblast-mediated cardiac fibrosis has not been directly evaluated in vivo. Here, we examined pressure overload-induced cardiac fibrosis in fibroblast- and myofibroblast-specific inducible Cre-expressing mouse lines with selective deletion of the TGF-β receptors Tgfbr1/2, Smad2, or Smad3. Fibroblast-specific deletion of Tgfbr1/2 or Smad3, but not Smad2, markedly reduced the pressure overload-induced fibrotic response as well as fibrosis mediated by a heart-specific, latency-resistant TGF-β mutant transgene. Interestingly, cardiac fibroblast-specific deletion of Tgfbr1/2, but not Smad2/3, attenuated the cardiac hypertrophic response to pressure overload stimulation. Mechanistically, loss of Smad2/3 from tissue-resident fibroblasts attenuated injury-induced cellular expansion within the heart and the expression of fibrosis-mediating genes. Deletion of Smad2/3 or Tgfbr1/2 from cardiac fibroblasts similarly inhibited the gene program for fibrosis and extracellular matrix remodeling, although deletion of Tgfbr1/2 uniquely altered expression of an array of regulatory genes involved in cardiomyocyte homeostasis and disease compensation. These findings implicate TGF-β-Smad2/3 signaling in activated tissue-resident cardiac fibroblasts as principal mediators of the fibrotic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts (45–48). Furthermore, fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype (49–52), for example, loss of SMAD3 lowers the number of activated myofibroblasts in cardiac fibrosis in vivo and reduces extracellular matrix production by myofibroblasts”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“By contrast, cultured human primary cardiac and dermal fibroblasts and immortalized cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ (refs. 19,39,40), IL-1β (ref. 41)) conditions.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“TGF-β1 activates SMAD2/3 signaling, driving pro-fibrotic gene expression and extracellular matrix deposition in cardiac fibroblasts [85].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [85]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, primary human cardiac fibroblasts, primary human dermal fibroblasts, and immortalized human cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ 20,33,34 , IL-1 β 35 ) conditions.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“While numerous studies have implicated a role for TGFβ signaling in maladaptive cardiac remodeling and scar formation in HF 20,33”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · cited 1×
“Heart failure is an increasingly prevalent disease characterized by reduced cardiac output resulting from a progressive loss of cardiomyocytes, ventricular chamber remodeling, and accumulation of interstitial fibrosis (1).”
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528 · cited 1×
“Global TGF-β activity is upregulated in diseased hearts, where one of its primary actions is directed at the resident fibroblasts to alter the fibrotic response and ventricular remodeling (47, 48).”
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jew082 · Cited by 2,425 · cited 1×
“The ratio of these measures ( E/e ′ ) was used as an indicator of diastolic function (60).”
Cardiac Fibroblast: The Renaissance Cell
Souders, C. A., Bowers, S. L. K., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 984 · cited 1×
“Progressive cardiac fibrosis in heart failure is predominantly mediated by the tissue-resident cardiac fibroblast, which becomes activated and then differentiated into a cell type referred to as the myofibroblast (5, 6).”
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934 · cited 1×
“TGF-β is considered a “master” cytokine/growth factor produced within injured or diseased tissues, where it activates fibroblasts and facilitates ECM production (15, 16).”
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 6×
“Hence, here we used mice in which the Postn genetic locus was targeted with a tamoxifen-inducible MerCreMer (MCM) cDNA (29), and these mice were crossed with Smad2 fl/fl , Smad3 fl/fl , Smad2/3 fl/fl , and Tgfbr1/2 fl/fl targeted mice (Figure 2A).”
InfluentialSelf-citation
Cited by
Items 801–900 of 925
Cardioprotective Roles of Hydrogen Sulfide Donor Treatment in Diabetic Cardiomyopathy
Kar, S. (2020) · DigitalCommons@UNMC
The Effects of Growth Differentiation Factor 11 on Pathological Cardiac Hypertrophy
Harper, S. C. (2018) · TUScholarShare (Temple University)
Montoya, A. (2009) · Fotogramas & DVD: La primera revista de cine
BMP7 as a multifactorial growth factor for cartilage homeostasis
Ripmeester, E. G. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210930er
Conservation Treatment Job # 6630
Horne, A. R. (1875)
A little fat never hurt anybody: how fat can influence wound healing
El-Hattab, M. Y., Worthington, K. S., Ankrum, J. A., Klingelhutz, A. J., Sander, E. A., & Raghavan, S. M. L. (2021) · doi:10.17077/etd.006291
Abual’anaz, B. M., Rattan, S. G., & Dixon, I. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-14952-8_13
Effects of dihydroartemisinin on cardiac fibroblast activity induced by angiotensin II
Cai, A., Li, J., Li, Y., Ma, H., Shan, T., Zhang, S., Miao, G., & Li, Z. (2023) · Materials Express · doi:10.1166/mex.2023.2425
Mwafy, M. E. F. A., eskander, F., Attia, M. M., mishriki, E., & hamama, M. (2023) · The Egyptian Journal of Histology · doi:10.21608/ejh.2023.218351.1909
Recommendation: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R0/PR3
(2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr3
Recommendation: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R2/PR9
(2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr9
Recommendation: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R1/PR6
(2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr6
Review: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R0/PR2
(2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr2
Decision: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R1/PR7
(2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr7
Author comment: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R1/PR5
Halliday, B. P. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr5
Decision: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R2/PR10
(2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr10
Author comment: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R0/PR1
Halliday, B. P. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr1
Author comment: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R2/PR8
Halliday, B. P. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr8
Decision: Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? — R0/PR4
(2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.24.pr4
Li, J. L. Y., Li, F., Niu, L., An, B., Cheng, X., Liu, Y., & Wang, J. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.11.14
Toprak, K., Kaplangöray, M., Özen, K., Koyuncu, İ., Taşcanov, M. B., Altıparmak, İ. H., Biçer, A., & Demirbağ, R. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231222239
Brg1 regulates fibroblast-myofibroblast transition to promote renal fibrosisPreprint
Wu, X., Luo, Y., Kang, A., Ni, J., Kong, M., & Zhang, T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.22.572996
Gaynor, T. L., Hsu, I., Krstevski, C., Farrugia, G. E., Dona, M. S. I., Cohen, C. D., Drew, B. G., & Pinto, A. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.06.578860
“…of Erg(+) and Tal1(+) both important for EC homeostasis and angiogenesis 43,44 , Tfec(+) and Irf5(+) both implicated in macrophage functions and polarisation 45,46 , Meox1(+) and Smad3(+) which govern fibroblast activation 47 , and TGFβ-directed fibrosis 48 in a cardiac context, respectively.”
BackgroundAjao, F. O., Balogun, D. A., Iyedupe, M. O., Ayobami, O., Esther, O., Adeniji, L., Victor, A., & Olaleye, F. E. (2024) · Journal of Cardiology and Cardiovascular Medicine · doi:10.29328/journal.jccm.1001177
Primary Cilia Confer TGFβ1-Dependent Resistance in Rat Cardiac Fibroblasts after X-Ray InjuryPreprint
Ma, C., Ma, X.-N., yang, J., Chang, J., & Fu, S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4797658
Single-Cell Transcriptional Survey of Murine Intestinal Graft-Versus-Host DiseasePreprint
Gao, F., Wu, H., Jin, X., Shi, Z., Wang, L., Pei, S., Huang, H., & Zhao, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4804115
Characterizing the Role of Palmitoylation in Cardiac Fibroblast Activation and Fibrosis
Goldsmith, R. (2024) · Deep Blue (University of Michigan) · doi:10.7302/23113
Zhu, X., Yang, B., Lu, Y., Zhang, M., Shi, Y., & Chen, J. (2024) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2024.06(06).13
“One study [23] found that specific deletion of TGF-β1 or Smad3 genes in activated mouse cardiac myofibroblasts attenuated pressure overload-induced cardiac fibrosis.”
BackgroundHsieh, J., Hall, M. A. L., Shameem, M., Erñst, P., Kamdar, F. D., Singh, B. N., Meisel, R. L., & Ogle, B. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.08.606705
Potential of anthocyanins to prevent age-related endothelial senescence and dysfunction
Chaker, A. B. (2021) · theses.fr (ABES) · doi:10.70675/ae0d733dz5068z4830zab87zeca36f00a5a7
CK1δ Is Implicated in TGF-β1 Activation of Human Lung Myofibroblasts
Li, M., Zhang, S. S., Harris, T., Chen, Q., & Stewart, A. G. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0421le
Pathological Mechanisms and Therapeutic Advances in Hypertensive Myocardial Fibrosis
薛, 琳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551479
Park, H., Park, B., Kim, K., Park, H., & Park, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136326
“There is limited direct evidence on the effects of HyperG exposure on cardiac fibrosis [17,18].”
Yang, B., Chen, J., Mi, Q., Huo, J., Gao, N., Lin, X., Molkentin, J. D., & Meng, Q. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.04.692460
Self-citationRole of non-classical monocytes in angiotensin II-induced cardiac remodelling
Shia, Y. X. (2025) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.35524
Chen, S., Wang, K., Fan, Z., Zhou, T., Li, R., Zhang, B., Chen, J., Chi, J., Wei, K., Liu, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734401
Chen, S., Wang, K., Fan, Z., Zhou, T., Li, R., Zhang, B., Chen, J., Chi, J., Wei, K., Liu, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734395
Zhang, M., Zhang, J., Hu, H., Zhou, Y., Lin, Z., Jing, H. C., & Sun, B. (2024) · Figshare · doi:10.6084/m9.figshare.26739921
Saw, E. L., Pearson, J. T., Schwenke, D. O., Munasinghe, P. E., Tsuchimochi, H., Rawal, S., Coffey, S., Davis, P., Bunton, R. W., van Hout, I., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14091345
Wang, A. Z., Bowman-Kirigin, J. A., Desai, R., Kang, L.-I., Patel, P. R., Patel, B., Khan, S. M., Bender, D. E., Marlin, M. C., Liu, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736402
Chen, S., Wang, K., Fan, Z., Zhou, T., Li, R., Zhang, B., Chen, J., Chi, J., Wei, K., Liu, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26045502
Rath, S. K., Nyamsuren, G., Tampe, B., Yu, D. S.-W., Hulshoff, M. S., Schlösser, D., Maamari, S., Zeisberg, M., & Zeisberg, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943555
Rath, S. K., Nyamsuren, G., Tampe, B., Yu, D. S.-W., Hulshoff, M. S., Schlösser, D., Maamari, S., Zeisberg, M., & Zeisberg, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943546
Ruolo dei fibroblasti cardiaci nella cardiotossicit� da doxorubicina
Ruggeri, C. (2020) · CINECA IRIS Institutial Research Information System (University of Genoa) · doi:10.15167/ruggeri-clarissa_phd2020-05-27
Rath, S. K., Nyamsuren, G., Tampe, B., Yu, D. S.-W., Hulshoff, M. S., Schlösser, D., Maamari, S., Zeisberg, M., & Zeisberg, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943558
Rath, S. K., Nyamsuren, G., Tampe, B., Yu, D. S.-W., Hulshoff, M. S., Schlösser, D., Maamari, S., Zeisberg, M., & Zeisberg, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943564
Ergir, E. (2023) · reposiTUm (TU Wien) · doi:10.34726/hss.2023.50391
Zhang, M., Zhang, J., Hu, H., Zhou, Y., Lin, Z., Jing, H. C., & Sun, B. (2024) · Figshare · doi:10.6084/m9.figshare.26739924
Min, L., Shu-Li, Z., Feng, Y., Han, H., Shao-Jun, L., Sheng-Xiong, T., Jia-Yu, T., Xiang-Zhi, F., & Dan, F. (2022) · Figshare · doi:10.6084/m9.figshare.19808072
Tan, C. Y., Chan, P. S., Tan, H., Tan, S. W., Lee, C. J. M., Wang, J.-W., Ye, S., Werner, H., Loh, Y. J., Lee, Y. L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24312982
Chen, S., Wang, K., Fan, Z., Zhou, T., Li, R., Zhang, B., Chen, J., Chi, J., Wei, K., Liu, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734410
Tan, C. Y., Chan, P. S., Tan, H., Tan, S. W., Lee, C. J. M., Wang, J.-W., Ye, S., Werner, H., Loh, Y. J., Lee, Y. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24312939
Rath, S. K., Nyamsuren, G., Tampe, B., Yu, D. S.-W., Hulshoff, M. S., Schlösser, D., Maamari, S., Zeisberg, M., & Zeisberg, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943561
Chen, S., Wang, K., Fan, Z., Zhou, T., Li, R., Zhang, B., Chen, J., Chi, J., Wei, K., Liu, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734398
Chen, S., Wang, K., Fan, Z., Zhou, T., Li, R., Zhang, B., Chen, J., Chi, J., Wei, K., Liu, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734407
Chen, S., Wang, K., Fan, Z., Zhou, T., Li, R., Zhang, B., Chen, J., Chi, J., Wei, K., Liu, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26045550
Rath, S. K., Nyamsuren, G., Tampe, B., Yu, D. S.-W., Hulshoff, M. S., Schlösser, D., Maamari, S., Zeisberg, M., & Zeisberg, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943549
Rath, S. K., Nyamsuren, G., Tampe, B., Yu, D. S.-W., Hulshoff, M. S., Schlösser, D., Maamari, S., Zeisberg, M., & Zeisberg, E. M. (2024) · Figshare · doi:10.6084/m9.figshare.26943552
Chen, S., Wang, K., Fan, Z., Zhou, T., Li, R., Zhang, B., Chen, J., Chi, J., Wei, K., Liu, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734404
THE ROLE OF TCF21 IN CARDIAC FIBROBLAST CELL NUMBER AND EXTRACELLULAR MATRIX REMODELING
Chen, J. (2023) · ScholarSpace (University of Hawaii at Manoa) · Cited by 1
Kebbe, M. (2024) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/30626
Volkovich, M. (2025) · eScholarship@McGill (McGill) · doi:10.82308/21652
Wang, F., Ma, Z., Latif, A., Zhan, C., Cui, C., Zhang, P., Cui, Q., & Zhang, J. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117699
Li, D., Zhong, D., Tan, T., Huang, Z., Wu, M., Liu, Y., Zhang, Y., Liu, C., Xu, J., & Xiang, F.-L. (2026) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2026.100837
“The Cre recombination efficiency is comparable to the previous study using the same Postn -MCM system generated by Dr. Molkentin [3,7].”
Quan, M., Xie, T., Harris, L. A., & Luo, H. (2026) · ACS Omega · doi:10.1021/acsomega.5c12886 · Cited by 1
Qian, C., Pei, Z., Yang, Z., Sun, M., Zhang, Y., Liu, H., & Sun, Y. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl47751
Cardiac Fibrosis: Mechanobiology, Epigenetics, and the Path to Precision Therapy
Hamouz, M., Hammouz, R. Y., Caruana, C., Micallef, D., Bednarek, A. K., & Dingli, P. F. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00896-z
Contrôle de l’homéostasie des macrophages de la pulpe rouge splénique par une niche fibroblastique
Bellomo, A. (2020) · theses.fr (ABES) · doi:10.70675/595aad77zb764z48bfz8e7dzc4d373e8001a
Exploration of autophagy modulation in cancer and infectious diseases
Bestion, E. (2021) · theses.fr (ABES) · doi:10.70675/3663f1cdz2637z4b11za0afza7e39569a2fc
ML216 Alleviates Age-Related Cardiac Fibrosis by Suppressing TGF-β1 Signaling Pathway
Liu, W., Cui, F., Huang, X., Liang, N., & Li, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083425
“…of the TGF-β superfamily and a central pro-fibrotic cytokine, activates SMAD2/3 (Mothers against decapentaplegic homolog 2/3) cascade as well as TAK1/p38 pathways [21,22], leading to the upregulation of pro-fibrotic genes including collagens and connective tissue growth factor (CTGF) [23–25].”
Harnessing the gut microbiome for precision therapeutics in heart failure
Li, J., Zhang, S., Zhang, Y., 王鑫磊, Zhuge, Y., Wu, Q., Zhao, Y., Gao, Q., Chen, R., Wang, Y., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1781470 · Cited by 1
“High TMAO levels are associated with poor HF prognosis and can promote platelet activation (Duttaroy, 2021), induce myocardial fibrosis (Khalil et al., 2017), and facilitate arrhythmogenesis (Fan et al., 2023; Yu et al., 2018).”
VAP1 promotes cardiac fibrosis by enabling PDGFR signaling in myofibroblasts
Huang, S., Zhao, Q., Shao, T., Zhu, C., Xue, Y., Chen, N., Zhang, Y., Xu, H., Kong, M., & Wang, R. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01690-7 · Cited by 1
Molecular Targets and Emerging Therapeutics in Cardiac Fibrosis
Mohan, N., & Sruthi, R. (2026) · Fibrosis · doi:10.70322/fibrosis.2026.10007
Optimized Cardiac Health by Exercise: Cardiomyocytes and Immune Microenvironment
Liu, S., Hu, M., Li, X., Li, G., Crețoiu, D., Bowen, T. S., Sluijter, J. P. G., Bei, Y., & Xiao, J. (2026) · Physiology · doi:10.1152/physiol.00008.2026
Huang, W., Guan, T., Yan, Z., Cui, Y., Bi, S., Wu, M., & Yuan, D. (2026) · Cardiorenal Medicine · doi:10.1159/000551330
Grisanti, L. A., & Nekouian, S. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1792252
LepR+ Fibroblasts in Maladaptive Cardiac Fibrosis: Mechanisms and Controversies
Frangogiannis, N. G. (2026) · Circulation Research · doi:10.1161/circresaha.126.328411
Shao, Q., Chen, D., Shao, W., & Ye, Q. (2026) · Research · doi:10.34133/research.1326 · Cited by 1
“In the fibrotic process, fibroblasts are key effector cells that promote fibroblast activation through signaling pathways such as the Wnt/ β -catenin [ 109 ], TGF-β [ 110 , 111 ], and PDGF [ 112 ] pathways, thereby increasing extracellular matrix deposition and exacerbating tissue fibrosis.”
Yu, X., Du, X., Zuo, G., & Liu, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114877
“As the dominant effector of the canonical TGF-β signalling axis, SMAD3 is phosphorylated at its C-terminal SSXS motif following TGF-β RI activation, facilitating nuclear translocation and transcriptional upregulation of profibrotic genes including COL1A1, ACTA2, and FN1 [27,43,44].”
Xbp1s regulates cardiac fibrosis by transcriptionally activating Stat3 in mice
Dong, Y., Su, H., Zheng, P., Tao, Z., Chen, Z., Han, P., Zhang, L., & Liu, Y. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102276
Escobar, B., Menendez-Montes, I., Albendea-Gomez, T., Mendoza-Tamajon, S., Castro-Mecinas, R., Urra-Balduz, S., Palacios, B., Gomez, M. J., Díaz-Díaz, C., Sánchez‐Cabo, F., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.076230 · Cited by 1
Cardiomyocytes Undergo a Mesenchymal-Like Fate Transition in Myocardial FibrosisPreprint
Wang, T., Zhou, C., Liu, M., Xing, Y., Han, C., Li, R., Huang, Y., Li, Z., Teng, Y., Yang, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.10.731493
Calcium dysregulation in diabetic cardiomyopathy & heart failure with preserved ejection fraction
Ali, A., Sharma, V. M., & Aguilar-Sánchez, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1872513
Cartilage intermediate layer protein (CILP) in cardiac fibrosis: Protective or pathogenic?
Corrales-Terrón, M., Rossi, C., Krause, J., Schroen, B. L. M., Herum, K. M., & van Nieuwenhoven, F. A. (2026) · Matrix Biology · doi:10.1016/j.matbio.2026.102032 · Cited by 1
Zhou, R., Cai, D., & Chen, S. (2026) · Cells · doi:10.3390/cells15131202
“Genetic studies have shown that Smad3 deletion attenuates fibrosis in multiple organs [16], while Smad2 deletion leads to early embryonic lethality and disrupts neural crest development [17], suggesting non-redundant functions.”
Humeres, C. D., Tuleta, I., Qin, D., Shinde, A. V., Deepak, A., Hanna, A., & Frangogiannis, N. G. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045203
“18,52,53 Both in vitro and in vivo evidence suggests high responsiveness of cardiomyocytes to TGF-β stimulation.”
Inflammatory and hormonal crosstalk linking rheumatic fever to chronic valvular heart disease
Chen, J., Fan, Q., Sang, J., Kong, S., Sun, X., & Zhang, K. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12294-9
“Meanwhile, the over-activation of TGF-β/Smad and NF-κB signaling pathways drives the continuous remodeling of ECM, result - ing in the thickening and stiffening of valve tissue [ 15, 71, 72].”
Zhan, L., Xiang, H., Kong, Y., Lei, Y., Xiao, S., Chen, S., Li, J., Li, Z., Ni, R., Peng, D., et al. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70249
“10 Moreover, the pathogenesis of HS involves a complex multi-stage, multi-pathway regulatory network.”
Legumain (asparaginyl endopeptidase) modulates extracellular matrix dynamics in pulmonary fibrosisPreprint
Rigoux, B., David, A., Sizaret, D., Allouche, R., LEBOUCHE, C., Vanderlynden, L., Lecaille, F., Poręba, M., Veillard, F., Marchand-Adam, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.20.739492
“Consequently, Smad-3 deficiency attenuates fibrosis and alters wound repair dynamics [56, 57].”
Yi, C., Zheng, W., Zhao, J., Cai, W., Wang, J., Song, L., Bai, M., & Zhang, Z. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146537
Yang, H., Yu, K., & Liang, B. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/4189404
“TGF-β promotes cardiac fibroblast activation, collagen synthesis, and extracellular matrix accumulation through canonical SMAD signaling and non-SMAD pathways, including mitogen-activated protein kinase (MAPK) and PI3K-AKT signaling [18, 19].”
Su, Z., Shen, H., Sun, J., Kong, X., & Sun, W. Y. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.049049
Ferreira, L. A., Oliveira, M. C., Santos, R. M., & Costa, A. P. (2026) · Advanced Journal of Biomedicine & Medicine · doi:10.18081/ajbm.2026.2.150
Wang, X., Zhou, L., Ding, H., Zhang, W., Zhu, Y., Li, B., Wang, H., Yu, R., Wang, J., Zhu, M., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122270
Long, T., Ma, J., Hu, W., Wang, Q., Xie, Z., Wu, S., & Wu, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167075
“Accordingly, fibroblast-to-myofibroblast transition and dysregulated ECM turnover represent the principal downstream phenotypic hub shared by these pathways [59,112].”
Metadata
- Authors
- Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., Karch, J., & Molkentin, J. D.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Johns Hopkins University (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2017-09-11
- Volume
- 127
- Issue
- 10
- Pages
- 3770-3783
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5617658
- OpenAlex
- W2750808153
- Cited by
- 905
- References
- 64
- Citations by year
- 2026: 92 · 2025: 102 · 2024: 128 · 2023: 121 · 2022: 144 · 2021: 110 · 2020: 84 · 2019: 85 · 2018: 34 · 2017: 2
- FWCI
- 43.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Language arts journal of Michigan (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (158486, 148429)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL069779, R01HL105924)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR060636)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- myocardial fibrosis, TGF-beta signaling, Smad2, Smad3, cardiac fibroblasts, myofibroblasts, TGF-beta receptor, pressure overload, cardiac hypertrophy, extracellular matrix remodeling
- MeSH terms
- Receptor, Transforming Growth Factor-beta Type I, Receptor, Transforming Growth Factor-beta Type II, Animals, Fibrosis, Heart Diseases, Male, Mice, Transgenic, Myocardium, Organ Specificity, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Myocytes, Cardiac, Mice, Smad2 Protein, Smad3 Protein, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.